Member Info for itsallamess

Timo loading up, spending the big bucks, maija tweeting agreeing to exciting news on clevergen soon...

Anyone feeling very confident that we may see the elusive shareholder value

For days we have had solid buys and they are pushing the share price down!

I'm a believer :)

For the believers.. RNS? Incoming?

literally just looking at this!

Election of members of the Board member, Anne Whitaker a citizen of the United States and the right to issue 10 million shares up to june 2022!

Preperation for the uS listing?

Any thoughts?

Two 1 share trades... RNS incoming???

(this is what happens when waiting for news :)

Cwebb, 360 as I type... Feeling very bullish today..

Would love some news to drop and the SP rise to 10 quid :)

News this quarter on data from clevegen Markku says!

A US listing would make our small finnish company so much larger and more accessible.

Also it any perspective partners will see that their investment would be in a company with links to the US.

At the momemet we are trading on the scand market... Hardly a big deal outside of the scandy countries and the big mighty British AIM market (a bask of crocadiles)

So I say bring it on... With just 52 million shares and around 25%only in the free float (Acually I've lost track what size the free float is) as they say, hold onto your golden tickets!

I reckon they are getting things in line for a YS listing.

Once this happens then there will be no stock availible!

Quesera

Excellent observation.
What caught my eye was the on the bottom ofv he financial statement, from the chairman:
"Harnessing the immune system to fight cancer using immunotherapy has, undoubtedly, been one of the most exciting breakthroughs in modern science and the first wave of pioneering treatments changed the face of cancer treatment. We know these therapies do not work for everyone and many patients who initially respond will eventually relapse. Combining immunotherapies with complementary approaches is becoming increasingly important in cancer treatment and bexmarilimab's expanded clinical development programme, investigating its combination with existing treatments, will provide important evidence of its potential use as a future combination therapy."

Combination therapy being the key here!

https://www.proactiveinvestors.co.uk/companies/news/944883/faron-pharma-making-progress-in-finding-potential-partners-for-clevegen-and-traumakine-944883.html

https://www.faron.com/pipeline

That's right, they will trial for Traumakine in protecting organs when transplanting

Faron has no control over remap timings ect..

Under Traumakine... Anyone know what this is about?
"Preclinical work on solid organ transplant"

The Board anticipates the following pipeline progress and catalysts during 2021:

Clevegen:
· Summary of data from MATINS Part I
· Final CLEVER-1 occupancy data
· Top line data from MATINS Part II
· First patient in neoadjuvant CRC and RCC
· Final dosage and dose frequency decision
· Selection of first pivotal cohort from MATINS trial
· First patient in NSCLC PD(L)1 combination
· First patient in haematological malignancies
· Pre-clinical evaluation in multiple new tumour types

Traumakine:
· Initiation of HIBISCUS
· Anticipated REMAP-CAP interim read out
· Formation of a Traumakine Scientific Advisory Board
· Interim analysis from HIBISCUS
· Preclinical work on solid organ transplant
· Partnering update during 2021

AOC3 Antagonist Platform Technology:
· Additional information from pre-clinical studies with humanised AOC3 mice and with ex vivo human cells during 2021

Conference call information

A virtual briefing and Q&A session for analysts will be hosted by Dr. Markku Jalkanen, Chief Executive Officer, and Toni Hänninen, Chief Financial Officer, at 12:00 pm GMT / 2:00 pm EET / 8:00 am EST on the day of results. The Full-year results release for 2020, presentation, webcast details, and Annual Report 2020 will be made available at www.faron.com/investors. A replay of the analyst briefing will be made available shortly afterwards.

Webcast link: https://www.lsegissuerservices.com/spark/FaronPharmaceuticalsOy/events/04110470-3c65-4dad-ba56-54b27e83f27f

On one of the recent interviews with Marku when asked about the WHO you could tell he was very annoyed about the way they run the study and how they took his interferon, and either never used it or never collected data on the few results.

The WHO in how they have dealt with covid from the outset and their sucking up to China have been a disgrace IMO

Much the same as ever year.

Agreeing on keeping the BOD, paying their annual 35k ect...

Voiting on the new board member is interesting, a American! Wonder if this has anything to do with the future US listing requirement?

ALSO OUR cfo exceriseing his right to buy 40000 shares ate the bargain price of 98p lucky fellow :) I assume it's from his annual renumeration money...

Very true cwebb! Really encouraged by the nice little rise today!

I feel like faron runs with a pattern.
News > rise that day > level out > them nice rises over a couple of weeks

I probably jinks it now!